Forest Laboratories LLC v. Amneal Pharmaceuticals LLC
1:15-cv-00430
Overview
Parties
Defendant
Amneal Pharmaceuticals Co. India Pvt. Ltd. Operating Company
Represented By
2 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
The Corporate Plaza, 800 Delaware Ave.
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Amneal Pharmaceuticals of New York LLC Operating Company
Represented By
2 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
The Corporate Plaza, 800 Delaware Ave.
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Amneal Pharmaceuticals LLC Operating Company
Represented By
5 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
The Corporate Plaza, 800 Delaware Ave.
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Plaintiff
Forest Laboratories Holdings Ltd. NPE (Patent Assertion Entity)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Forest Laboratories LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,763,476 Asserted | Asserted Patent | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 94,200,521 | European Counterpart (EP) | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 1995023600 A1 | PCT World Application | View Official Patent → |
Forest Laboratories LLC v. Alembic Pharmaceuticals Ltd.
Forest Laboratories LLC v. Sigmapharm Laboratories LLC
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5763476
Sublingual or buccal pharmaceutical composition
|
Filed: 1995-03-01
Issued: 1998-06-09
|
Expired (Term Ended)
+1927d PTA
Expires: 2020-06-09
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1927 days) / Cellect Scrutiny — Over 1927 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings